Johnson & Johnson Newsroom

On the first day of the JPM Medical Conference, pharmaceutical giants are announcing new strategies. Could the mergers and acquisitions in Biomedical begin in 2025?

In 2025, the Biomedical mergers and acquisitions will begin.

wallstreetcnJan 14 19:01

Looking Into Johnson & Johnson's Recent Short Interest

Benzinga03:15

Johnson & Johnson (JNJ) Among the Best Dividend Kings to Buy Now

Yahoo Finance02:33

S&P has placed Johnson & Johnson (JNJ.US) on negative credit watch.

The rating agency S&P has placed Johnson & Johnson (JNJ.US) on a credit watch with a negative outlook, primarily due to the company's acquisition of the mental health drug developer Intra-Cellular Therapies for nearly 15 billion USD. S&P believes that this acquisition will raise Johnson & Johnson's adjusted leverage ratio to about 1.4 times, exceeding the downgrade trigger of 1 time set by S&P's ratings. Johnson & Johnson added that it expects its adjusted leverage ratio to decline to 1.1 times by the end of 2025 and to below 1 time by the end of 2026.

AASTOCKS02:31

Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty

Benzinga01:41

S&P Places Johnson & Johnson on CreditWatch Negative

WSJ01:07

Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?

Zacks Jan 14 21:05

Trump Looms Large Over Stock Markets. Why Chips, -2-

Barron'sJan 14 20:11

BofA Securities Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166

Futu NewsJan 14 18:38 · Ratings

Express News | Trellus Health - Entered Deal With Johnson & Johnson Health Care Systems to Support Pilot in US to Assess Potential for Trellus Elevate Program

BreakingsJan 14 15:07

Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166

Futu NewsJan 14 09:31 · Ratings

Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal -- Update

WSJJan 14 04:12

Intra-Cellular Therapies Stock Is Surging Monday: What's Going On?

BenzingaJan 14 03:58

Equities Mixed Intraday as Markets Await Bank Earnings, Inflation Data

MT NewswiresJan 14 03:38

Sector Update: Health Care

MT NewswiresJan 14 02:49

Dean Omar Branham Shirley's Partners Named to List of 500 Leading Lawyers in America

BusinesswireJan 14 02:06

UnitedHealth, Caterpillar Share Gains Contribute To Dow's 240-Point Climb

MarketWatchJan 14 01:59

US Equity Indexes Mixed as Magnificent-7 Stocks Decline Amid Gains in Treasury Yields

MT NewswiresJan 14 01:24

Is Johnson & Johnson (JNJ) the Most Reliable Dividend Stock to Buy According to Hedge Funds?

Yahoo FinanceJan 14 01:02

Top Midday Stories: Moderna Shares Fall After 2025 Revenue Guidance Cut; Cleveland-Cliffs Reportedly Teams Up With Nucor in Potential Bid for US Steel

MT NewswiresJan 14 00:54